4.5 Review

A clinical approach to the investigation and management of long COVID associated neuropathic pain

Related references

Note: Only part of the references are listed.
Review Neurosciences

Electrophysiological assessment in patients with COVID-19-related peripheral neuropathies and myopathies: a systematic review

Sarah Al-Mazidi et al.

Summary: The study reviewed clinical studies on COVID-19 peripheral neuropathy and found that some patients had neurological symptoms. By correlating patients' symptoms and characteristics with nerve conduction studies/electromyography (NCS/EMG) outcomes, it was found that the main manifestation was myopathy, with a few cases of polyneuropathy. The median nerve was particularly associated with the severity and motor recovery rate of COVID-19 patients.

JOURNAL OF NEUROPHYSIOLOGY (2023)

Review Microbiology

Long COVID: major findings, mechanisms and recommendations

Hannah E. Davis et al.

Summary: Long COVID is a common and debilitating illness that affects at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, with a wide range of symptoms and impacts on multiple organ systems. There are an estimated 65 million individuals worldwide with long COVID, and the number of cases is increasing daily. Current diagnostic and treatment options are insufficient, and there is a need for clinical trials to address leading hypotheses. Future research should account for biases and testing issues, build on viral-onset research, include marginalized populations, and meaningfully engage patients.

NATURE REVIEWS MICROBIOLOGY (2023)

Review Medicine, General & Internal

The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis

Lauren L. O'Mahoney et al.

Summary: This study systematically synthesized global evidence on the prevalence of persistent symptoms in a general post COVID-19 population. The findings show that regardless of hospitalization status, at least 45% of COVID-19 survivors experience unresolved symptoms for about 4 months. The current understanding of Long Covid is limited by heterogeneous study design, follow-up durations, and measurement methods, hindering effective treatment and management strategies.

ECLINICALMEDICINE (2023)

Article Clinical Neurology

Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study

A. A. Tamborska et al.

Summary: Uniform case definitions are necessary for consistent reporting of neurological syndromes associated with SARS-CoV-2. Clinicians from various countries and specialties were invited to assess anonymised vignettes of SARS-CoV-2 neurological syndromes. The study revealed high diagnostic accuracy for most cases, but difficulties in diagnosing encephalitis, encephalopathy, and psychosis.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Review Medicine, General & Internal

COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis

Laura Dawn Williams et al.

Summary: This systematic review aimed to investigate the prevalence and determinants of neuropathic pain among individuals infected with COVID-19. The results showed that the prevalence of COVID-19-related neuropathic pain was 6.7% for hospitalized patients during the acute phase and 34.3% for long COVID patients. Risk factors for COVID-19-related neuropathic pain development included depression, COVID-19 severity, and azithromycin use.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Clinical Neurology

COVID-19-Related Burning Eye Syndrome and Burning Mouth Syndrome: A Systematic Review and Meta-analysis

Laura D. Williams et al.

Summary: This systematic review and meta-analysis aimed to establish the prevalence of COVID-19-related burning eye syndrome (BES) and burning mouth syndrome (BMS) and describe their phenomenology. The results showed that the pooled prevalence of COVID-19-related BES was 9.9%, while the frequency of COVID-19-related BMS has not been thoroughly investigated but female patients are more susceptible. Both BES and BMS are associated with the severity of COVID-19. Further research is needed on the manifestations of these syndromes in long COVID syndrome.

PAIN AND THERAPY (2023)

Review Anesthesiology

Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis

Cesar Fernandez-de-las-Penas et al.

Summary: This review or meta-analysis aims to analyze the prevalence of musculoskeletal pain symptoms after COVID-19 infection among hospitalized or nonhospitalized patients. The analysis showed that nearly 10% of individuals infected with SARS-CoV-2 will experience musculoskeletal post-COVID pain symptoms during the first year after infection.
Article Anesthesiology

Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study

Cesar Fernandez-de-las-Penas et al.

Summary: This study investigated the prevalence and risk factors of long-term musculoskeletal post-COVID pain in COVID-19 survivors. The study found that 45.1% of survivors experienced musculoskeletal post-COVID pain 8 months after hospital discharge, and risk factors included female sex, history of musculoskeletal pain, presence of myalgia and headache as COVID-19 symptoms, and days at hospital.
Editorial Material Multidisciplinary Sciences

Nervous system consequences of COVID-19

Serena Spudich et al.

Summary: Understanding the pathophysiological mechanisms behind neurological symptoms is crucial.

SCIENCE (2022)

Article Multidisciplinary Sciences

Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort

Viet-Thi Tran et al.

Summary: About 10% of people infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience post COVID-19 disease. This study analyzed data from a French disease cohort and found that among patients symptomatic after 2 months, 85% still reported symptoms one year after their symptom onset. Symptoms showed different trends over time, with some decreasing, some remaining stable, and some increasing in prevalence. The study provides important insights into the natural history of post COVID-19 disease.

NATURE COMMUNICATIONS (2022)

Article Clinical Neurology

Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID

Anne Louise Oaklander et al.

Summary: This study analyzed the neuropathy conditions in patients with long COVID and found that small-fiber neuropathy after mild SARS-CoV-2 infection was the most common, with difficulties in treatment.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Review Clinical Neurology

Neuropathic Pain Associated with COVID-19: a Systematic Review of Case Reports

Deepika Joshi et al.

Summary: Patients with COVID-19 may experience neuropathic pain within weeks or months following infection, which can sometimes lead to worsened neurological complications and increased pain. This systematic review analyzes case reports of neuropathic pain during and after COVID-19 infection, revealing several cases of herpes zoster, intense burning pain, trigeminal neuralgia, and brachial plexopathy associated with COVID-19.

CURRENT PAIN AND HEADACHE REPORTS (2022)

Review Public, Environmental & Occupational Health

Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis

Rizaldy Taslim Pinzon et al.

Summary: This article is a systematic review and meta-analysis of persistent neurological manifestations in COVID-19 survivors. The study found that the most common symptom in long COVID-19 patients is fatigue, followed by cognitive disorder, paresthesia, sleep disorder, musculoskeletal pain, and dizziness. Neurological manifestations are prevalent and persisting in patients, but the duration of symptoms varies.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)

Article Medicine, General & Internal

The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series

Teresa Grieco et al.

Summary: This study aimed to provide pathological evidence of neurosensory skin system involvement in COVID-19 patients with subjective neurological symptoms affecting the skin. The histopathology findings suggest hypertrophy of nerve endings, similar to a condition called dermal hyperneury, which could explain the sensory abnormalities experienced by the patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, General & Internal

Possible complex regional pain syndrome following SARS-CoV-2 infection: Case report

Balasubramaniam Branavan et al.

Summary: SARS-CoV-2 infection can lead to neurological and musculoskeletal system damage, including small fiber neuropathy. Complex regional pain syndrome is a debilitating neurological disorder characterized by pain and involvement of other sensory, motor, autonomic, and trophic functions.

SAGE OPEN MEDICAL CASE REPORTS (2022)

Article Medicine, General & Internal

Neuropathic pain post-COVID-19: a case report

Matthew McWilliam et al.

Summary: A 61-year-old man with no significant medical history developed acute severe burning pain affecting his whole body and subsequently distally in the limbs after testing positive for SARS-CoV-2, with all tests showing normal results. His pain was inadequately controlled with pregabalin but improved while on a weaning regimen of steroids. This case highlights the variety of possible symptoms associated with SARS-CoV-2 infection.

BMJ CASE REPORTS (2021)

Article Immunology

Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics

Jana L. Hirschtick et al.

Summary: The study found that post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) is highly prevalent, especially among cases reporting severe initial symptoms. The prevalence of COVID-19 at 30 and 60 days post-onset was high even among nonhospitalized respondents and those reporting mild symptoms.

CLINICAL INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Complex regional pain syndrome after severe COVID-19-A case report

Ana Vaz et al.

Summary: Neurological complications in ICU patients with COVID-19, such as peripheral nerve lesions, can have various causes and may increase the risk of developing Complex Regional Pain Syndrome. A multidisciplinary approach for early diagnosis and treatment is crucial for intervention and prognosis of nerve injuries.

HELIYON (2021)

Article Neurosciences

Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample

Haidy Elshebawy et al.

Summary: Through this study, we found that polyneuropathies related to COVID-19 can manifest in different forms and may occur in different waves of the pandemic. Early neurological symptoms may impact treatment plans and prognosis, and further research is needed on the pathophysiology and therapeutic options for these neuropathies.

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2021)

Review Medicine, General & Internal

Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis

Cesar Fernandez-de-las-Penas et al.

Summary: This meta-analysis revealed that more than 60% of patients with SARS-CoV-2 infection experienced post-COVID-19 symptoms. Fatigue and dyspnea were the most prevalent post-COVID-19 symptoms, especially at 60 and >= 90 days after onset.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Article Pediatrics

Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study

Stephen T. J. Ray et al.

Summary: This UK study on children with SARS-CoV-2 infection and neurological or psychiatric complications identified key differences between those with primary neurological disorders and those with PIMS-TS, highlighting the need for further investigation into underlying mechanisms and longer-term outcomes.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Review Neurosciences

Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic

Nadine Attal et al.

Summary: COVID-19 commonly presents with respiratory symptoms, but pain is also a common symptom, some of which may be neuropathic. Various viral infections like herpes zoster and HIV can cause neurological complications including neuropathic pain, and COVID-19 can also lead to neurological complications that may result in chronic neuropathic pain. Longitudinal cohort studies are needed to evaluate the exact risk of neuropathic pain after COVID-19.

PAIN REPORTS (2021)

Review Clinical Neurology

Guillain-Barre syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature

Erika Scheidl et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2020)

Editorial Material Medicine, General & Internal

Survivorship after COVID-19 ICU stay

Megan M. Hosey et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Article Neurosciences

A COVID-19 patient with intense burning pain

Feyzullah Aksan et al.

JOURNAL OF NEUROVIROLOGY (2020)

Article Clinical Neurology

Neuromuscular presentations in patients with COVID-19

Vimal Kumar Paliwal et al.

NEUROLOGICAL SCIENCES (2020)

Article Medicine, General & Internal

Acute transverse myelitis in COVID-19 infection

Chian Chiang Nicholas Chow et al.

BMJ CASE REPORTS (2020)

Review Anesthesiology

A Comprehensive Algorithm for Management of Neuropathic Pain

Daniel Bates et al.

PAIN MEDICINE (2019)

Review Pharmacology & Pharmacy

Neuropathic pain: current definition and review of drug treatment

Bridin P. Murnion

AUSTRALIAN PRESCRIBER (2018)

Article Clinical Neurology

EAN guidelines on central neurostimulation therapy in chronic pain conditions

G. Cruccu et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Clinical Neurology

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

Nanna B. Finnerup et al.

LANCET NEUROLOGY (2015)

Review Clinical Neurology

Central post-stroke pain: clinical characteristics, pathophysiology, and management

Henriette Klit et al.

LANCET NEUROLOGY (2009)

Review Neurosciences

Mechanisms of neuropathic pain

James N. Campbell et al.

NEURON (2006)